China Life Private Equity Investment Company Limited
国寿股权
China Life Private Equity Investment Company Limited (国寿股权 / 国寿股权投资) is the specialized private equity investment platform of China Life Insurance, established in June 2016 . It manages the China Life Health Fund (国寿大健康基金), which was the first insurance-funded private equity investment fund approved under relevant CBIRC policies and has since deployed dozens of investments in healthcare .
The firm typically invests as a lead investor in growth-stage rounds. It led XtalPi's $46 million Series B+ in 2018 and participated as a follow-on investor in the company's subsequent $300 million-plus funding in 2020 . Other lead investments include METiS Pharmaceuticals' two consecutive rounds totaling $150 million in 2022 alongside PICC Capital , SinoChips Technology's Series D in early 2023 , and CasCade Therapeutics' nearly 500 million yuan round in early 2026 . It also appears in 暗涌Waves's mapping of state-backed investors active in new energy alongside SDIC funds and social security capital .
AI-generated — may contain errors, please verify.
Coverage
CasCade Therapeutics Closes Nearly 500 Million Yuan Major Funding Round, Targeting Nuclear Receptor and GPCR Innovative Drug R&D
Dedicated to becoming a global leader in metabolic disease therapeutics.
高榕创投·Year-end good news: CDH Investments has raised 5 billion yuan for logistics investments.
Insurance capital is turning its attention to real estate investments.
暗涌Waves·Money, Contradictions, and ESG
*Who Cares Wins*
暗涌Waves·A Complete Map of China's Industrial Investment: When the Gears of Fate Begin to Turn
Seven sectors, 200 investments, 500 funds — all in nine charts.
暗涌Waves·SinoChips Technology Closes Hundreds of Millions of RMB in Series D Funding, Doubles Down on New Power Semiconductor Devices
Further increase R&D investment and capacity expansion in areas such as automotive and new energy.
高榕创投·Three Barometers for the Primary Market, for Your Reference
The bilateral order of the primary market is being restructured on both sides.
暗涌Waves·New Tracks, Interdisciplinary Fields, Down-Market Expansion, Data Infrastructure... Four Companies Raise Nearly 1.2 Billion RMB in Funding | FreeS Family Funding News · Vol 10
Looking forward to working alongside more outstanding founders.
峰瑞资本·5Y News | METiS Pharmaceuticals Closes Two Consecutive Rounds Raising $150 Million Total
Become an industry innovation leader.
五源资本·Morningside-backed XtalPi raises over $300 million in new funding | Light Moments
5Y Capital has long been bullish on the application of computational science in the life sciences, hoping that the convergence of IT and biotechnology will soon usher human health into a new era.
五源资本·XtalPi Closes $46 Million Series B+ Round | FreeS Fund Deal Brief
Empowering drug R&D organizations worldwide.
峰瑞资本·
